Christina Brooks, MD
Pain Medicine · Appleton, WINPI 1609307958
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,103 of the $14,259 with a category attached, or 63.8%. 11 manufacturers reported payments, led by Medtronic at 48.0% of the total. Reporting peaked in 2022 at $8,970 and has fallen 91.2% since, to $793 in 2025.
Across 138 payments — averaging $103.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Abbott$4K
- Boston Scientific$1K
- Si-bone, Inc.$566
- SPR Therapeutics, Inc$345
- Nevro Corp.$290
- plus $605 from 5 others
What the payments were for
- Travel & lodging$9,10364%
- Food & beverage$5,15636%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 65 | $6,845 |
| Abbott | 26 | $4,231 |
| Boston Scientific | 23 | $1,378 |
| Si-bone, Inc. | 4 | $566 |
| SPR Therapeutics, Inc | 8 | $345 |
| Nevro Corp. | 3 | $290 |
| Vertos Medical, Inc. | 3 | $287 |
| Globus Medical | 1 | $138 |
| AstraZeneca | 2 | $97 |
| Bioventus LLC | 2 | $66 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,699
- SYNCHROMEDII$2,077
- OSTEOCOOL RF ABLATION SYSTEM$1,550
- PRODIGY$1,069
- INTELLIS ADAPTIVESTIM$882
- Superion Indirect Decompression System$759
- VANTA ADAPTIVESTIM$624
- Omnia$266
- mild Device Kit$148
- Senza$138
- SPRINT PNS System$111
How this compares
$14,259 in reported general payments places this provider in the 80th percentile of 82 pain medicine providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 38 | $970 |
| Duloxetine Hcl | 45 | $676 |
| Gabapentin | 44 | $515 |
| Tizanidine Hcl | 38 | $215 |
| Methocarbamol | 23 | $196 |
| Meloxicam | 24 | $160 |
| Cyclobenzaprine Hcl | 20 | $126 |
| Diclofenac Sodium | 11 | $77 |
| Cephalexin | 17 | $55 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Appleton
- Matthew FischerAppleton$21K
- Michael RoegnerAppleton$3K
- Brenton MeierAppleton$1K
- Taha JamilAppleton$577
- Alaa Abd-ElsayedMadison$1.3M
- Michael JungWest Bend$339K
- Frederick FreitagMadison$157K
- Atit ShahSheboygan$76K
- Thomas FaullMadison$66K
- Ammar MahmoudNeenah$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.